Alzheimer's & Dementia

Alzheimer’s disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills. Alzheimer’s is the most common cause of dementia among older adults. Dementia is the loss of cognitive functioning—thinking, remembering, and reasoning—and behavioral abilities to such an extent that it interferes with a person’s daily life and activities.

Alzheimer’s Disease | Definition, Causes, Diagnosis & Treatment

Alzheimer’s Disease (AD) is the most common form of dementia worldwide (60-70% of all dementia cases) and is a progressive neurodegenerative disorder.

What is Dementia?

Differences Between Alzheimer's and Dementia

Alzheimer's Disease Causes

AAM - Genetics of Alzheimer's

Alzheimer's Disease Symptoms

Alzheimer's Disease Diagnosis

Alzheimer's Disease Treatments

AAM - The Search for a Cure to Alzheimer's

Alzheimer's Disease Questions

Alzheimer’s tangles and plaques: what’s the difference?

Alzheimer's Disease Epidemiology

See more featured articles »

Pollution and Alzheimer's

AAM - Air pollution and Alzheimer's

Is Alzheimer's Disease Transmissible?

Diet and Alzheimer's Disease

Types of Alzheimer's Disease

Stem Cell Therapy for Alzheimer's

Alzheimer's and Veganism

Biomarkers for Alzheimer's Disease

Alzheimer's Disease Prevention

Inflammation and Alzheimer's Disease

Integrated PET/MR for Alzheimer’s Disease

Gender and Alzheimer’s Risk

Alzheimer's Disease and Sleep Disruption

Does Herpesvirus Cause Alzheimer's?

Does Type 2 Diabetes Increase the Risk of Alzheimer’s Disease?

Can Statins Protect Against Alzheimer’s Disease?

Stress and Alzheimer's Disease

Alzheimer's Disease and the Microbiome

Amyloid Cascade Hypothesis

Omega-3 and Alzheimer’s Disease

Antibody Research and Alzheimer’s Disease

Alzheimer’s Disease and Calcium Supplements

Alzheimer’s Disease and Gingko Biloba

Do Antioxidants Benefit Patients with Alzheimer’s and Parkinson’s?

What Causes Dementia?

Dementia Diagnosis

Dementia Prevention

Dementia Symptoms

Dementia Treatment

Dementia with Lewy Bodies

Bright Light Therapy and Dementia

Aromatherapy for Dementia

Coconut Oil and Dementia

What is Mixed Dementia?

Transcutaneous Electrical Nerve Stimulation for Dementia

Childhood Dementia Causes

Mixed Dementia Prevention and Treatment

Mixed Dementia Symptoms and Diagnosis

Childhood Dementia Signs and Symptoms

Does Type 2 Diabetes Increase the Risk of Alzheimer’s Disease?

Parkinson's Compared to Dementia with Lewy Bodies (DLB)

Antidepressants and Dementia: Is There a Link?

Does Depression and Anxiety Increase the Risk of Dementia?

Migraines and Dementia

What are Amyloid Plaques?

Can Happiness Protect You from Dementia?

Mythbusting: Misconceptions in Dementia

Designing Dementia-Friendly Environments

Dancing Through Dementia: How Movement Aids Memory and Mood

Latest Alzheimer's & Dementia News and Research

Anxiety’s Long-Term Impact on Dementia Development

The longitudinal relationship between chronic, resolved, and new onset anxiety and the risk of all-cause dementia (Progressive cognitive decline affecting memory and thinking).

26 Jul 2024

COVID pandemic accelerated brain aging, especially in males and deprived groups

The COVID-19 pandemic accelerated brain aging, particularly in males and those from deprived backgrounds, with significant cognitive performance decline in infected individuals. This impact was observed regardless of COVID-19 infection status, highlighting the role of psychosocial stressors.

25 Jul 2024

New review highlights advances in diabetes research and treatment

A new paper surveying advances in diabetes pathogenesis and treatment explores the complex factors contributing to the onset and progression of the disease, suggesting that an understanding of these dynamics is key to developing targeted interventions to reduce the risk of developing diabetes and managing its complications.

25 Jul 2024

New brain atlas reveals hidden cell vulnerabilities in Alzheimer's

Researchers created a detailed transcriptomic atlas of six brain regions, revealing cell-type-specific and region-specific vulnerabilities in Alzheimer's disease and highlighting astrocyte genes linked to cognitive resilience.

25 Jul 2024

UK initiative aims to transform MND research through health data collaboration

MND is a devastating disease affecting the motor neurones in the brain and spinal cord, leading to progressive muscle weakness and paralysis.

25 Jul 2024

Experimental cancer drug could make thinking easier for individuals with Rett syndrome

An experimental cancer drug could make thinking easier for individuals with Rett syndrome, a rare disorder linked to autism, according to new research from the University of California San Diego -; a discovery that could lead to therapies for patients with other neurological conditions.

25 Jul 2024

Novel antisense therapy targets α-synuclein pathologies in neurodegenerative diseases

TMDU researchers demonstrate proof of concept of antisense nucleic acid therapy to prevent the spread of α-synuclein pathologies in synucleinopathies.

25 Jul 2024

Finnish research reveals higher incidence of early-onset dementia among working-age adults

A new major study by the University of Eastern Finland, the University of Oulu and Neurocenter Finland explored early-onset dementia in the working-age population in Finland.

25 Jul 2024

Recombinant shingles vaccination found to lower dementia risk

The effects of recombinant shingles vaccines on dementia.

25 Jul 2024

Unprecedented brain cell mapping sheds light on Alzheimer's

Less than a decade ago, when Dr. Hansruedi Mathys launched an ambitious project to create an annotated library of all the gene readouts stored within 100 individual brain cells, the task felt daunting.

25 Jul 2024

Comprehensive analysis of Alzheimer’s brain tissue identifies novel biomarkers

From studying the human genome, to analyzing the way proteins are encoded, or monitoring RNA expression, researchers are rapidly gaining a far richer understanding of the complex genetic and cellular mechanisms that underpin dementia. But there's a catch: While new technologies are revealing myriad avenues for Alzheimer's research, it's impossible to know in advance which research pathways will lead to effective treatments.

25 Jul 2024

Cognitive decline persists in older adults long after severe COVID-19 recovery

Older adults recovering from COVID-19 experience varying degrees of cognitive decline over 2.5 years, with severe cases showing the most significant impact. Early cognitive care and monitoring are crucial for improving outcomes.

24 Jul 2024

Oligodendrocytes identified as key amyloid β producers in Alzheimer's disease

Researchers discovered that oligodendrocytes, not just neurons, produce amyloid β in Alzheimer's disease, and suppressing their activity improves disease pathology. This finding suggests new therapeutic targets for Alzheimer's treatment.

24 Jul 2024

High belly and arm fat linked to Alzheimer's and Parkinson's risk

People with high levels of body fat stored in their belly or arms may be more likely to develop diseases like Alzheimer's and Parkinson's than people with low levels of fat in these areas, according to a study published in the July 24, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology.

24 Jul 2024

Traffic-related ultrafine particles impair mitochondrial function in human olfactory cells

Ultrafine particles, UFPs, the smallest contributors to air pollution, hinder the function of mitochondria in human olfactory mucosa cells, a new study shows.

24 Jul 2024

Creating the first genetically susceptible mice for late-onset Alzheimer's

Mice don't get Alzheimer's-;and while that's good news for mice, it's a big problem for biomedical researchers seeking to understand the disease and test new treatments.

24 Jul 2024

Breakthrough research identifies fibrin as key factor in preterm brain bleeds

Mark Petersen, MD, has seen firsthand the devastating effects of brain bleeds in premature babies. It's an exceedingly common condition that affects up to 20 percent of infants born before 28 weeks of gestation, bringing an increased risk for developmental delays and autism.

24 Jul 2024